Edwards Lifesciences is a medical device company focused on innovative therapies for patients with heart valve disease and other cardiovascular conditions. The company develops and commercializes transcatheter technologies, including the SAPIEN M3 Transcatheter Mitral Valve Replacement Therapy, designed to address unmet clinical needs for patients with mitral and tricuspid heart valve disease. Their Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit pursues innovative portfolios to help patients live longer and healthier lives through advanced minimally invasive treatment options.
Industry
Medical Devices
Company Size
5001-10000 employees
Remote Policy
Hybrid
Edwards Lifesciences
Edwards Lifesciences
Edwards Lifesciences
Edwards Lifesciences
Beta · Sourced from candidate reports
25%
Response Rate
—
Avg Response
0 rounds
Interview Rounds
Based on 4 candidate reports
Sarah received a rejection email from Edwards Lifesciences stating they selected another candidate with more qualifications and experience.
The candidate has not yet received a response from Edwards Lifesciences as of June 15, 2026.
Eria Elis Garnica did not receive a response or interview callback from Edwards Lifesciences after applying.
The applicant has not heard back from Edwards Lifesciences.
